Graham P A, Mooney C T, Murray M
Department of Veterinary Clinical Studies, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, Scotland.
Res Vet Sci. 1999 Oct;67(2):171-5. doi: 10.1053/rvsc.1998.0302.
Serum fructosamine concentrations were measured in 35 healthy cats and in 30 hyperthyroid cats before and 30 days after curative radioiodine ((131)I) treatment. Hyperthyroid cats were divided into those with 30 day post-treatment total thyroxine (T4) concentrations within (EuT4) or below (HypoT4) the reference range. The median (semi-interquartile range, SIR) fructosamine concentration was significantly lower in hyperthyroid compared with healthy cats (295. 0 (18.5) micromol l(-1)) both before (254.0 (27.6) micromol l(-1)) and after (268.5 (28.0) micromol l(-1)) treatment (P < 0.001 in each case). (131)I therapy was associated with increases in serum fructosamine (mean increase 20.4 micromol l(-1), P = 0.039) and total protein (6.3 g l(-1), P < 0.002) in the HypoT4 group and in globulin concentration in both EuT4 (5.9 g l(-), P < 0.002) and HypoT4 (5.2 g l(-1), P = 0.023) groups. There were no direct relationships between the observed elevations in fructosamine concentration and those in total protein or globulin concentrations suggesting that the effect may be due to reduced rates of protein turnover. Reduced values may need to be considered when interpreting serum fructosamine concentrations for monitoring the degree of glycaemic control in diabetic cats with concurrent hyperthyroidism.
在35只健康猫以及30只甲状腺功能亢进猫接受放射性碘(¹³¹I)治疗前和治疗后30天测量血清果糖胺浓度。甲状腺功能亢进猫被分为治疗后30天总甲状腺素(T4)浓度在参考范围内(EuT4)或低于参考范围(HypoT4)的两组。与健康猫相比,甲状腺功能亢进猫治疗前(254.0(27.6)微摩尔/升)和治疗后(268.5(28.0)微摩尔/升)的果糖胺浓度中位数(半四分位间距,SIR)显著更低(295.0(18.5)微摩尔/升)(每种情况P<0.001)。¹³¹I治疗与HypoT4组血清果糖胺升高(平均升高20.4微摩尔/升,P = 0.039)、总蛋白升高(6.3克/升,P<0.002)以及EuT4组(5.9克/升,P<0.002)和HypoT4组(5.2克/升,P = 0.023)球蛋白浓度升高有关。观察到的果糖胺浓度升高与总蛋白或球蛋白浓度升高之间没有直接关系,这表明该效应可能是由于蛋白质周转率降低所致。在解释血清果糖胺浓度以监测并发甲状腺功能亢进的糖尿病猫的血糖控制程度时,可能需要考虑降低的值。